Fresh Equities
ASX:AFP

ASX:AFP

AFT PHARMACEUTICALS LIMITED

4W AVG VOLUME
8.15
Data provided by Weblink | as of close 2020-01-24
4W AVG TURNOVER
$25.265

AFT PHARMACEUTICALS LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
< $50k
Investors Interested in Next Raise
< 10
How Fresh Equities Works
Authentication

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

Authentication

2. View Terms

View the full term sheet for the capital raise.

Authentication

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Loading...


Company Overview

AFT Pharmaceuticals Limited (AFP) is a growing multinational pharmaceutical business with a broad range of products, both developed itself and in-licensed from third parties. AFT''s products cover all major pharmaceutical distribution channels: over-the-counter, prescription and hospital.

Type

Listed Company

GICS Sub-industry

Pharmaceuticals

Head Office

Level 1/129 Hurstmere Rd, Takapuna, Auckland 0622, New Zealand

Pharmaceuticals
Health Care
Biotech & Health

Price Chart


Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.

Fresh Equities does not have AFT PHARMACEUTICALS LIMITED quarterly cash flows data.


Directors

Fresh Equities does not have AFT PHARMACEUTICALS LIMITED directors data.


Announcements

All
All Time
    Letter to Shareholders on 22 January 2020

    Progress Report

    Amended notice - Appendix 3B on 16 December 2019

    Issued Capital

    Appendix 3B on 16 December 2019

    Issued Capital

    AFT secures Maxigesic IV distribution in Indonesia on 10 December 2019

    Progress Report

    AFT welcomes new codeine medicine restrictions on 4 December 2019

    Progress Report

  • Letter to Shareholders on 25 November 2019

    Progress Report

  • Half Yearly Report and Accounts on 20 November 2019

    Periodic Reports

    Half Yearly Report and Accounts on 20 November 2019

    Periodic Reports

  • Half Yearly Report and Accounts on 20 November 2019

    Periodic Reports

  • Half Yearly Report and Accounts on 20 November 2019

    Periodic Reports

  • Load More

News

Loading...